With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. In the latest twist, Pfizer’s Comirnaty partner BioNTech chalked up a win as the European Patent Office (EPO) snatched back one of Moderna’s patents, ruling it...
In a recent Nature Communications paper published on November 8, 2023, Dr. Zhen Xie’s team from Tsinghua University introduced the PROMITAR platform, designed to enable programmable translational control in circular mRNA, a significant innovation in RNA-based...
Nonprofit standards organization, U.S. Pharmacopeia (USP), has given a talk as part of efforts to raise awareness of its standards for biologics including mAbs and vaccines. USP, which aims to build trust in medicines through public quality standards, says that many...
Several biotech companies, including Moderna, are exploring the use of mRNA infusions to enhance the body’s immune cells for fighting cancer and other diseases, offering a novel approach to CAR-T cell therapies. Instead of the labor-intensive process of...
